DeepScribe, an AI-enabled clinical documentation tool for healthcare providers, is partnering with oncology-focused digital health company Flatiron Health to bring DeepScribe's AI documentation to clinicians that use Flatiron's OncoEMR, cloud-based electronic medical record platform.
According to the company, DeepScribe's ambient AI is "optimized for oncology by comprehending the workflow,...
DexCare scored $50 million in a Series B funding round led by Transformation Capital. Existing investors Kaiser Permanente, Providence Ventures, Mass General Brigham, Define Ventures, Frist Cressey Ventures and SpringRock Ventures also participated.
The Series B comes less than a year after a $20 million fundraise from March.
The Providence Health spinout offers a platform for health systems to...
PathAI, a Boston-based artificial intelligence pathology company, has closed a Series C funding round worth $165 million.
The round was co-led by D1 Capital Partners and Kaiser Permanente, with additional participation from General Atlantic, Tiger Global Management, 8VC, Adage, Biospring Partners, General Catalyst, KdT Ventures, Polaris Partners, Refactor Capital, and strategic partners Bristol-...
_8_2.jpeg?itok=KZzR9a6I)
